About Cenetron
Cenetron is a company based in Austin (United States) founded in 1995 by Dwight DuBois was acquired by Versiti in July 2019. Cenetron offers products and services including Collection Kit Design, Assay Development, and Regulatory Services. Cenetron operates in a competitive market with competitors including Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
- Headquarter Austin, United States
- Founders Dwight DuBois
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cenetron
Cenetron offers a comprehensive portfolio of products and services, including Collection Kit Design, Assay Development, and Regulatory Services.
Design and assembly of kits for specimen collection in trials
Development and validation of biomarkers for research purposes
Guidance on regulatory strategies and filings for trials
Funding Insights of Cenetron
Detailed funding history for Cenetron
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cenetron
Cenetron has secured backing from 1 investor. Prominent investors backing the company include Versiti.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Blood bank
|
Locked | Locked | Locked |
Investor details for Cenetron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cenetron
Investment portfolio details for Cenetron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cenetron
Detailed financials for Cenetron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cenetron Comparisons
Peer comparison for Cenetron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cenetron
Cenetron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Cenetron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cenetron
Complete news archive for Cenetron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cenetron
Cenetron was founded in 1995.
Cenetron is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Founded in 1995 in Austin, United States, Cenetron operates in the clinical trial sector. Customized specimen collection kits, data management, laboratory reports, and trial site support are provided. End-to-end sample collection solutions are handled, along with complete central laboratory services that encompass protocol review, technology consultation, laboratory testing, and clinical study data management.
Cenetron's top competitors include Emmes, Syneos Health and ClinChoice.
Cenetron offers Collection Kit Design, Assay Development, and Regulatory Services.
Cenetron has 1 investor. Key investors include Versiti.